3 steps to accelerate Decentralized trials & Release to patients

A collage illustrating three steps for clinical trials: vaccine vials, data analysis, and a healthcare professional.
Seamless monitoring of direct-to-patient shipments within an end-to-end calculation engine enables a digital release in patient's homes. Site centric technology also allows for a decentralized and proactive approach, reducing waste. Furthermore, digitalizing temperature management end-to-end enables a faster release of products for all types of trials and creates a foundation for successful decentralized drives.
TSS Clinical Module

One thing that the pandemic taught us was that we can do things much faster than we initially thought. However, when it comes to waiting for a conclusion on the temperature excursion, it's still normal that it takes days, or even weeks. Recently, a leading pharmaceutical company decided to go from manual Excel files and move to an automated calculation engine, to release products in seconds instead of days.

Other sponsors have implemented automated technology at clinical sites to help site staff spend less time on manual tasks and more time with patients. Digitalizing  and automating temperature management also enables a seamless and fast release to patients in decentralized trials.

1. How to achieve a 93% time-reduction in temperature management  

When looking at the temperature chain for trial products, every time a temperature excursion occurs, the evaluation of that excursion takes a lot of time and manual effort. In the end, most of those excursions do not result in a deviation and the product is in fact OK to use. Potential rescheduling of patient visits could have been avoided.

More stakeholders and higher risk for temperature excursions further down the supply chain.

Apart from the fact that time savings are cost savings, why do we want to reduce the time the product spends in quarantine?First, to reduce the failed patient visits. From the patient's perspective, this might be a lifesaving treatment. But also, if they are driving several hours to get onto site to get this dispensed, they are not very happy to be rescheduled and must do that same journey again.

When reducing the waiting time and the rescheduling, we may as well lower the risk of patient dropouts, which of course is very expensive and can even compromise the total length of the trial.Timeliness of the trial also gets increasingly important with higher amounts of personalized medicine and specialized trials.

Temperature data uploads throughout the supply chain accumulated and compared against stability data in an automated calculation engine.

Having an automated way of managing temperature excursions can also contribute to sponsor attractiveness, as we are offering the site one single source of truth, instead of physical binders of paper files. The calculation engine provides inspection readiness as all data is at hand, just one click away. All data is fed to the  eTMF system and easily exported if needed.  

Reducing  the waiting time for a conclusion on a temperature excursion, can help prevent protocol deviations due to patients being dispensed with a temperature affected product during that time.

By reducing the time that kits are in quarantine due to evaluation of temperature excursions, there is less need for sending replacement products to sites. Reducing the automatic fill may even reduce the overproduction of clinical trial products, which has substantial effects on costs and sustainability.

Assuring the quality of the study drugs across the entire clinical supply chain through to Patients.

Implementing an automated calculation engines can reduce the time to evaluate a temperature excursion from days down to one second. For most excursions that, based on stability data, does not result in a deviation, the site knows instantly that the product is OK to use.

For the part of excursions that need further evaluation, the site is notified to keep products in quarantine and await a conclusion from the Sponsor. The Sponsor is also directly notified to take action on a potential deviation and can process the conclusion within the calculation engine.

The calculation engine integrates key components in the clinical ecosystem. It holds the stability data profiles of the product and compares every new temperature upload from shipments and storage with the stability data set on kit level. From the CTMS system integration comes trial and site data, and from the IRT orRTSM, shipment ID's and Kit IDs and their statuses are received. The calculation engine can also integrate with sponsor data lakes or eTMF systems.

Over the recent couple of years, some sponsors have taken automation even further, by implementing wireless technology at clinical sites. This technology is increasingly popular, not only with the sponsors, but also from the clinical site perspective.

2. How to boost site efficiency in temperature monitoring by 90%

Clinical sites are burdened with complexity as different trials and sponsors operate various hardware and software solutions. Also, there is a mix of high- and low-quality devices. Many temperature monitoring devices provide low quality data, risk of human error, as well as a high failure rate.

When a wireless solution for clinical site temperature monitoring was offered, there was instantly a pull from the sites to get their hands on this technology. They realized it would save them a lot of time, but as well, provide the future benefit of potentially being able to have just one set of hardware, feeding the data to different sponsors. Equally important, it is proven to be plug and play solution, with close to zero support tickets on how to setup the equipment.

The TSS TempMonitor BLE logger and TSS CCIS software.

Temperature data is sampled every 5 minutes and sent automatically over cellular networks or Wi-Fi to the online calculation engine. It provides instant notifications on temperature alarms so that site staff  can act faster to prevent temperature excursions in their storage areas. It also provides a global real-time overview for the sponsor, as all data is available in the calculation engine.

The benefits of site efficiency by fully connected monitoring
  • A reduction of 90% in time spent on temperature monitoring activities for clinical sites.
  • A reduction in temperature monitoring activities for the Sponsor team by 1700 hours per year.
  • Ability to prevent future excursions and reduce wasted trial products.

With the increase of more sensitive medicines, the ability to prevent future temperature excursions becomes increasingly important. From the big data set of temperature measurements from these devices, predictive analytics or machine learning, allows for creating alerts before product quality is compromised. For example, in failing storage environments, we can predict future extreme temperatures, and save more products from being wasted. This type of data trending is already used in detecting risk levels in shipment routes.

3. How to enhance patient experience with a unified digital release

The benefits of digitalizing temperature management, and automating excursion reporting, create a foundation for successful decentralized trials. The TSS calculation engine, expands to cater for releasing at patient's homes. As a first step, the distributor can upload USB shipment temperature loggers to the calculation engine. In the near future will the upload be made seamlessly by a Bluetooth logger, integrated with the patient app and the IRT, for a unified digital release at patient's home.

Learn more about TSS Clinical Module >

You may also be interested in

Mind the gap: the real-world impact of data gaps in clinical trials

Although clinical trials can cover a huge range of formats, from small academic assessments to global, multi-billion dollar ventures, they all have one thing in common. Their success (or failure) is determined by a consistent approach to data.
Read moreDownload Whitepaper
A manager using a tablet to oversee a network of planes, trains, and trucks, illustrating an automated supply chain.

How GSK Pharma in UAE optimized the supply chain through automatization

Is it possible to cut costs, increase efficiency, and improve quality—all at the same time? The GSK (GlaxoSmithKline) UAE division and their main logistics company GAC (Gulf Agency Company) exceeded their expectations when they implemented temperature monitoring solutions from TSS in outbound shipments from Dubai. Additionally, they reassured the safety of what's most valuable—the patient.
Read moreDownload Whitepaper
An image for NECSO Cambridge 2023, with the words "Clinical Trial" on a high-tech interface.

NECSO Cambridge 2023

Where do the majority of your temperature excursions occur? Why not eliminate them?
Read moreDownload Whitepaper

You may also be interested in

How To Minimise the Environmental Impact of Cloud Operations

When people think about sustainability transitions in pharmaceutical supply chains, they often focus on reducing product waste, or optimising transportation. These are both important initiatives, but there's another part of the equation that often goes unnoticed: the digital infrastructure powering modern supply chains.
Read more
A map of Europe with flags marking the different countries, representing the international audience of LogiPharma Europe 2025.

Join Us at LogiPharma Europe 2026

From Temperature Data to Release Decisions—Rethinking Supply Chain Control
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.